Hepatitis B Virus Reactivation Induced by Infliximab Administration in a Patient with Crohn’s Disease

Table 2

HBV markers in patients treated with infliximab.

Age	Sex		HBsAg	Anti-HBs	Anti-HBc s/co	HBV reactivation	Entecavir
47	F	Crohn	(+)				(+)
54	F	Crohn	(−)	(+)	(+) 6.41	(−)	(−)
47	M	Crohn	(−)	(−)	(+) 1.62	(+)	(+)
55	F	Crohn	(−)	(−)	(−) 0.9
64	F	UC	(−)	(−)	(−) 0.09
19	M	Crohn	(−)	(−)	(−) 0.05
34	M	Crohn	(−)	(−)	(−) 0.11
52	F	UC	(−)	(−)	(−) 0.07
43	M	Crohn	(−)	(−)	(−) 0.09
38	M	Behçet	(−)	(−)	(−) 0.11
52	M	UC	(−)	(−)	(−) 0.08
18	F	Crohn	(−)	(−)	(−) 0.05
42	M	Crohn	(−)	(−)	(−) 0.15
41	M	UC	(−)	(−)	(−) 0.07
23	M	Crohn	(−)	(−)	(−) 0.14

Crohn: Crohn’s disease, UC: ulcerative colitis, Behçet: Behçet’s disease, M: male, F: female.